🔥🐔 BizChicken 🐔🔥
Companies Similar to Kezar Life Sciences, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Kiromic BioPharma, Inc.
ALEXIS-ISO-1, ALEXIS-PRO-1
Kiromic Bio Pharma, Inc. is an artificial intelligence-driven allogeneic cell therapy company that develops multi-indication T cell therapies, leveraging the Gamma Delta T cell to target solid tumors. Key products include ALEXIS-ISO-1 and ALEXIS-PRO-1.
Symbol: KRBP
Recent Price: $0.93
Industry: Biotechnology
CEO: Mr. Pietro Bersani CPA, J.D.
Sector: Healthcare
Employees: 35
Address: 7707 Fannin, Houston, TX 77054
Phone: 832 968 4888
Leadership
- Pietro Bersani, CPA, Director
- Leonardo Mirandola, PhD, Chief Scientific Officer/Interim COO
- Scott Dahlbeck, MD, PharmD, Chief of Staff
- Brian Hungerford, Chief Financial Officer
- Michael Nagel, Chairperson
- Michael Catlin, Independent Director
- Pam Misajon, Independent Director
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Enzo Biochem, Inc.
Life Sciences Products
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company specializing in the research, development, manufacture, and marketing of diagnostic and research products using genetic engineering, biotechnology, and molecular biology. It operates through segments focused on Life Sciences Products, Clinical Laboratory Services, and Therapeutics.
About | About | About | About | About | Leadership | Locations | About | About | About | About | Careers | Benefits | Careers | About | Jobs | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | About | About | About | About
Symbol: ENZ
Recent Price: $0.70
Industry: Medical - Diagnostics & Research
CEO: Ms. Kara Cannon
Sector: Healthcare
Employees: 125
Address: 527 Madison Avenue, New York, NY 10022
Phone: 212 583 0100
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
Immuneering Corporation
IMM-1-104 and IMM-6-415
Immuneering Corporation is a biopharmaceutical company focused on developing oncology and neuroscience product candidates, with key products like IMM-1-104 for cancer treatment and IMM-6-415 for solid tumors.
Symbol: IMRX
Recent Price: $2.25
Industry: Biotechnology
CEO: Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Sector: Healthcare
Employees: 66
Address: 245 Main Street, Cambridge, MA 02142
Phone: 617 500 8080
Last updated: 2024-12-31
Kodiak Sciences Inc.
KSI-301
Kodiak Sciences Inc., a clinical stage biopharmaceutical company based in Palo Alto, California, specializes in developing therapeutics for retinal diseases. Their lead product candidate, KSI-301, is a potential treatment for various retinal conditions and is currently in Phase IIb/III clinical trials.
Symbol: KOD
Recent Price: $9.97
Industry: Biotechnology
CEO: Dr. Victor Perlroth M.D.
Sector: Healthcare
Employees: 111
Address: 1200 Page Mill Road, Palo Alto, CA 94304
Phone: 650 281 0850
Last updated: 2024-12-31
Kiora Pharmaceuticals, Inc.
KIO-301
Kiora Pharmaceuticals, Inc. develops therapies for ophthalmic diseases, with lead product KIO-301 in Phase 1 trial for vision restoration in degenerative retinal diseases and other products in trials for conditions like rheumatoid arthritis-related ocular issues and corneal wound repair.
Symbol: KPRX
Recent Price: $3.30
Industry: Biotechnology
CEO: Dr. Brian M. Strem Ph.D.
Sector: Healthcare
Employees: 12
Address: 1371 East 2100 South, Salt Lake City, UT 84105
Phone: 781 788 8869
Last updated: 2024-12-31
Keros Therapeutics, Inc.
KER-050
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for hematological and musculoskeletal disorders. Their lead product candidate, KER-050, targets cytopenias, including anemia and thrombocytopenia.
About | Management | Directors | Contact | About | Contact | Careers | Benefits | Careers | About | Benefits | About | Careers | Jobs | Careers | Careers | Careers
Symbol: KROS
Recent Price: $15.64
Industry: Biotechnology
CEO: Dr. Jasbir S. Seehra Ph.D.
Sector: Healthcare
Employees: 149
Address: 99 Hayden Avenue, Lexington, MA 02421
Phone: 617 314 6297
Leadership
- Jasbir Seehra, Ph.D., Board Member
- Keith Regnante, M.B.A., Chief Financial Officer
- Christopher Rovaldi, President, Chief Operating Officer
- Esther Cho, J.D., Senior Vice President, General Counsel
- John Oram, M.B.A., Senior Vice President, Program and Portfolio Management
- Robin Wagner, Senior Vice President, Human Resources
- Carl L. Gordon, Ph.D., C.F.A., Board Member
- Jean-Jacques Bienaimé, M.B.A., Lead Independent Director
- Nima Farzan, M.B.A., Board Member
- Mary Ann Gray, Ph.D., Board Member
- Tomer Kariv, J.D., Board Member
- Julius Knowles, M.B.A., Board Member
- Ran Nussbaum, Board Member
- Alpna Seth, Ph.D., Board Member
Last updated: 2024-12-31
Krystal Biotech, Inc.
beremagene geperpavec (B-VEC)
Krystal Biotech, Inc., a clinical stage biotechnology company, focuses on redosable gene therapy for treating serious rare diseases in the United States, with a pipeline of products at various stages of development.
Symbol: KRYS
Recent Price: $159.80
Industry: Biotechnology
CEO: Mr. Krish S. Krishnan M.B.A., M.S.
Sector: Healthcare
Employees: 229
Address: 2100 Wharton Street, Pittsburgh, PA 15203
Phone: 412 586 5830
Leadership
- Krish Krishnan, Board Member
- Suma Krishnan, Board Member
- Kathryn Romano, EVP & Chief Accounting Officer
- Laurent Goux, SVP & General Manager Europe
- Jennifer McDonough, SVP, Patient Access, Analytics and Operations
- Christine Wilson, Head of U.S. Sales and Marketing
- Hiroshi Kasamoto, General Manager Japan
- David Chien, SVP, Clinical Development
- Ramesh Arjunji, SVP, Global Value and Access
- John Thomas, General Counsel & Corporate Secretary
- Trevor Parry, VP, Research and Scientific Affairs
- Stéphane Paquette, VP, Business Development
- Mark A. Petrich, VP, Process Development and Validation
- Felino Obillo, VP, Global Supply Chain
- Julian Gangolli, Board Member
- Catherine Mazzacco, Board Member
- Kirti Ganorkar, Board Member
- Dino A. Rossi, Board Member
- Dan Janney, Board Member
- Chris Mason, Board Member
- Rand Sutherland, Board Member
Last updated: 2024-12-31
Kintara Therapeutics, Inc.
VAL-083, REM-001
Kintara Therapeutics is a clinical stage drug development company focused on developing and commercializing anti-cancer therapies for drug-resistant solid tumors.
About | Leadership | Directors | About | About | About | About | Contact | Careers | About | About | About
Symbol: KTRA
Recent Price: $0.22
Industry: Biotechnology
CEO: Mr. Jeffrey A. Bacha B.Sc., M.B.A.
Sector: Healthcare
Employees: 1
Address: 12707 High Bluff Drive, San Diego, CA 92130
Phone: 858 350 4364
Leadership
- Robert E. Hoffman, President, CEO, CFO and Chairman of the Board
- Greg A. Johnson, (Acting) Head of Operations
- Laura Johnson, Director
- Tamara A. Favorito, Director
- Robert J. Toth, Jr., M.B.A., Director
Last updated: 2024-12-31
Kura Oncology, Inc.
ziftomenib and tipifarnib
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company developing small molecule medicines for the treatment of cancer. It focuses on genetically defined subsets of acute leukemias and has a collaboration with Novartis for certain carcinoma treatments.
Symbol: KURA
Recent Price: $8.51
Industry: Biotechnology
CEO: Dr. Troy Edward Wilson J.D., Ph.D.
Sector: Healthcare
Employees: 142
Address: 12730 High Bluff Drive, San Diego, CA 92130
Phone: 858 500 8800
Last updated: 2024-12-31
Kymera Therapeutics, Inc.
novel small molecule therapeutics
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system.
About | About | Leadership | Foundation | Contact | Culture | About | About | Leadership | Foundation | About | About | About | Culture | Culture | Culture | Culture | About | About
Symbol: KYMR
Recent Price: $39.32
Industry: Biotechnology
CEO: Dr. Nello Mainolfi M.D., Ph.D.
Sector: Healthcare
Employees: 184
Address: 200 Arsenal Yards Boulevard, Watertown, MA 02472
Phone: 857 285 5300
Leadership
- Nello Mainolfi, Ph.D., Founder, President & CEO
- Jeremy Chadwick, Ph.D., Chief Operating Officer
- Ellen Chiniara, JD, Chief Legal Officer and Corporate Secretary
- Jared Gollob, MD, Chief Medical Officer
- Bruce Jacobs, CFA, MBA, Chief Financial Officer
- Karen Weisbach, Head of People and Culture
- Juliet Williams, Ph.D., Head of Research
- Bruce Booth, DPhil, Chairman and Co-Founder
- Felix J. Baker, PhD, Lead Independent Director
- Jeff Albers, JD, MBA,
- Pamela Esposito, PhD,
- Gorjan Hrustanovic, PhD,
- John Maraganore, PhD,
- Leigh Morgan,
- Victor Sandor, MDCM,
- Elena Ridloff, CFA,
Last updated: 2024-12-31
Kezar Life Sciences, Inc.
KZR-616
Kezar Life Sciences is a clinical-stage biotechnology company focused on developing novel small molecule therapeutics to address unmet needs in immune-mediated diseases and cancer in the United States.
About | About | About | About | Directors | About | Contact | Contact | Careers | Careers | Careers | Leadership | About | About | About | About | About | About | About | News | About | Careers | Contact | Careers | Careers | Careers | About | About | About | About
Symbol: KZR
Recent Price: $6.82
Industry: Biotechnology
CEO: Dr. Christopher J. Kirk Ph.D.
Sector: Healthcare
Employees: 58
Address: 4000 Shoreline Court, South San Francisco, CA 94080
Phone: 650 822 5600
Leadership
- Christopher Kirk, PhD, Chief Executive Officer, Co-Founder
- Marc Belsky, Chief Financial Officer
- Mark Schiller, Chief Legal Officer
- Neel K. Anand, DPhil, SVP, Research and Drug Discovery
- Zung To, SVP, Clinical Development
- Gitanjali Jain, SVP, Investor Relations and External Affairs
- Michelle Greenman, VP, Global Regulatory Affairs
- Jim Kirchner, PhD, VP, CMC and Supply Chain
- Andrew Basham, VP, Legal Affairs
- Dave Braggs, VP, Quality Assurance
- Pattie Chiang, SVP, Corporate Controller
- Tony Muchamuel, VP, Pharmacology & Toxicology
- Kiruthi Palaniswamy, PharmD, VP, Medical Affairs
- Mary Rogers, VP, Financial Planning & Analysis
- Joe Tedrick, VP, Human Resources
- Jinhai Wang, PhD, VP, Drug Metabolism & Pharmacokinetics
- John Fowler, Co-Founder
- Graham Cooper, Board Member, Beam Therapeutics, Former CFO, Receptos
- Franklin Berger, Founder
- Elizabeth Garner, MD, MPH, Chief Science Officer
- Michael Kauffman, MD, PhD, President, Chief Executive Officer, and Director
- Micki Klearman, MD, Former Group Medical Director
- Courtney Wallace, Venture Partner
Last updated: 2024-12-31
Nkarta, Inc.
NKX101 and NKX019
Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing cell therapies for the treatment of cancer. The company specializes in cellular immunotherapy using chimeric antigen receptors on natural killer cells to target tumor antigens.
About | Contact | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | About | Careers
Symbol: NKTX
Recent Price: $2.32
Industry: Biotechnology
CEO: Mr. Paul J. Hastings
Sector: Healthcare
Employees: 150
Address: 6000 Shoreline Court, South San Francisco, CA 94080
Phone: 415 582 4923
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Bio-Techne Corporation
Life Science Reagents, Instruments, and Services
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for research and clinical diagnostics globally, operating through segments like Protein Sciences and Diagnostics and Genomics.
About | ESG | Events | About | About | Contact | Careers | About | About | About | About | About
Symbol: TECH
Recent Price: $72.29
Industry: Biotechnology
CEO: Mr. Kim Kelderman
Sector: Healthcare
Employees: 3100
Address: 614 McKinley Place N.E., Minneapolis, MN 55413
Phone: 612 379 8854
Last updated: 2024-12-31
Alpha Teknova, Inc.
critical reagents for life sciences
Alpha Teknova, Inc. provides critical reagents enabling the discovery, development, and production of biopharmaceutical products, serving pharmaceutical, biotechnology companies, and research institutions.
About | About | About | News | Careers | About | About | About | Culture | About | About | About | About | About | About | About | About | About | About | About
Symbol: TKNO
Recent Price: $8.85
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Stephen Gunstream
Sector: Healthcare
Employees: 210
Address: 2290 Bert Drive, Hollister, CA 95023
Phone: 831 637 1100
Last updated: 2024-12-31
Xeris Biopharma Holdings, Inc.
Gvoke, Keveyis, Recorlev
Xeris Biopharma Holdings, Inc., a biopharmaceutical company headquartered in Chicago, engages in developing and commercializing therapies for endocrinology, neurology, and gastroenterology. Its products include Gvoke for hypoglycemia, Keveyis for primary periodic paralysis, and Recorlev for Cushing's syndrome, utilizing proprietary technology platforms, Xeri Sol and Xeri Ject.
Symbol: XERS
Recent Price: $3.38
Industry: Biotechnology
CEO: Mr. John P. Shannon
Sector: Healthcare
Employees: 377
Address: 180 North LaSalle Street, Chicago, IL 60601
Phone: 844 445 5704
Leadership
- John Shannon, Chief Executive Officer
- Beth P. Hecht, Chief Legal Officer and Corporate Secretary
- Kevin McCulloch, President and Chief Operating Officer
- Steve Pieper, Chief Financial Officer
- Allison Wey, Senior Vice President of Investor Relations and Corporate Communications
- Ken Johnson, Pharm.D., Senior Vice President, Global Development and Medical Affairs
- Kendal Korte, Senior Vice President of Human Resources
- Brian Conner, SVP, Quality and Chief Compliance and Risk Officer
- Marla S. Persky, Independent, Non-executive Chairperson of the Board
- Dawn Halkuff, Independent, Non-executive Board Member
- Garheng Kong, MD, PhD, Independent, Non-executive Board Member
- Ricki Fairley, Independent, Non-executive Board, Member: Co-founder and CEO of TOUCH, The Black Breast Cancer Alliance
- John Schmid, Independent, Non-executive Board Member
- BJ Bormann, Independent, Non-executive Board Member
- Jeffrey W. Sherman, Independent, Non-executive Board Member
- John H. Johnson, Independent, Non-executive Board Member: Reaction Biology Corp.
Last updated: 2024-12-31
Zura Bio Limited
ZB-168
Zura Bio Limited is a clinical-stage biotechnology company based in San Diego, California, focusing on developing novel medicines for immune and inflammatory disorders.
Symbol: ZURA
Recent Price: $2.55
Industry: Biotechnology
CEO: Mr. Robert Lisicki
Sector: Healthcare
Employees: 14
Address: 4225 Executive Square, San Diego, CA 92037
Phone: 858 247 0520
Last updated: 2024-12-31
Arcus Biosciences, Inc.
Cancer Therapies
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing and commercializing cancer therapies, with a pipeline including products like Etrumadenant, Zimberelimab, and Domvanalimab among others.
About | About | Leadership | Directors | About | Contact | Contact | Contact | Contact | Contact | Careers | About | About | About | About | Careers | About | Jobs | About | About
Symbol: RCUS
Recent Price: $14.91
Industry: Biotechnology
CEO: Dr. Terry J. Rosen Ph.D.
Sector: Healthcare
Employees: 577
Address: 3928 Point Eden Way, Hayward, CA 94545
Phone: 510 694 6200
Last updated: 2024-12-31